Parkinson's Blog

Could we stop Parkinson’s by feeding neurons copper?

The Join Parkinson’s Research (JPR) registry is a new online platform where people living with the condition can register to hear about the latest

UD study explores laser therapy to treat Parkinson’s

Northwestern Medicine find HPgV in brain samples of people with Parkinson’s, not in those without.

For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.

New research from Northwestern Medicine detects a common, but usually harmless virus in the brains of Parkinson’s patients

Parkinson’s disease often begins asymmetrically, affecting either the right or left side of the body first. Researchers from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) have demonstrated that this initial side of onset influences the progression of non-motor symptoms.

A safe and affordable treatment to slow the advancement of Parkinson’s dementia has emerged – in the form of a commonly available cough syrup that’s already being studied for its positive effect on other degenerative diseases.

Groundbreaking research by Sydney University found a new brain protein involved in Parkinson’s disease and a way to modify it to stop symptoms.

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over 12 months, whereas placebo patients worsened. Those with high-risk genes even saw cognitive gains, hinting at real disease-modifying power.